BioCentury
ARTICLE | Clinical News

EY-128: Started a Phase I/II trial

November 14, 1994 8:00 AM UTC

Telor Ophthalmic Pharmaceuticals Inc. (TELR) Product: EY-128 Indication: Maximize pupil size during cataract surgery Status: Started a Phase I/II trial ...